^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

PHGDH-L

i
Other names: PHGDH, Phosphoglycerate Dehydrogenase, D-3-Phosphoglycerate Dehydrogenase, 2-Oxoglutarate Reductase, Malate Dehydrogenase, Epididymis Secretory Protein Li 113, PHGDHD, 3PGDH , PGDH3, NLS1
Entrez ID:
Related biomarkers:
Associations
Trials
almost3years
Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma. (PubMed, BMC Med Genomics)
PHGDH plays a vital role in the development of endometrial cancer, which is related to tumor immune infiltration, and can be used as an independent diagnostic and prognostic marker for endometrial cancer.
Journal • IO biomarker
|
KRAS (KRAS proto-oncogene GTPase) • PHGDH (Phosphoglycerate Dehydrogenase)
|
CD8 expression • PHGDH overexpression • PHGDH-L
over3years
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. (PubMed, Nature)
In conclusion, although the catalytic activity of PHGDH supports cancer cell proliferation, low PHGDH protein expression non-catalytically potentiates cancer dissemination and metastasis formation. Thus, the presence of PHDGH heterogeneity in primary tumours could be considered a sign of tumour aggressiveness.
Journal
|
PHGDH (Phosphoglycerate Dehydrogenase)
|
PHGDH-L
over4years
Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer. (PubMed, Cancer Lett)
However, PHGDH knockdown efficiently suppressed PDAC cell growth and tumor growth under serine starvation. These findings provide evidence that targeting the serine biosynthesis pathway by inhibiting PHGDH is a potent therapeutic approach to eliminate PDAC cells in nutrient-deprived microenvironments.
Journal
|
KRAS (KRAS proto-oncogene GTPase) • PHGDH (Phosphoglycerate Dehydrogenase)
|
KRAS mutation • PHGDH-L